The trial-to-trial variability of neuronal responses and the correlated response variability among neurons are modulated by visual stimulus size in a manner that depends on cortical layer, suggesting ...
If your prompts influence policy, finance or patient care but live in chat threads, you don’t have innovation — you have unmanaged risk.
Benchmark eyes best close on record, ANZ beats forecasts; AMP sinks on profit fall, margins pressure; Origin upgrades outlook ...
This study provides a useful contribution to understanding how wearable augmentation devices interact with human proprioception, using a longitudinal design over a single session. Results demonstrate ...
The initial rush to deploy Generative AI has given way to a sobering reality for Hi-Tech and independent software vendor (ISV) enterprises. A clear operational divide is emerging. Many organizations ...
ADCs combine antibodies with drug payloads for targeted therapy, but complex manufacturing requires monitoring CQAs across multiple entities.
Primary and secondary outcome measures Children’s mental health was assessed using the Mental Health Test; parental anxiety and depression were measured with the Generalised Anx ...
Objectives To assess health-related quality of life (HRQoL), treatment satisfaction and associated factors among older adults with acute heart failure in Northwest Ethiopia. Design Prospective, ...
BACKGROUND: Mental stress-induced myocardial ischemia is often clinically silent and associated with increased cardiovascular risk, particularly in women. Conventional ECG-based detection is limited, ...
Blood p-tau217 testing in real-world practice enhances diagnostic accuracy and neurologists' diagnostic confidence, with the greatest diagnostic shifts seen in mild cognitive impairment and dementia.
Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to ...
MedPage Today on MSN
Alzheimer's 'Clock' Uses Blood Test to Forecast Symptom Onset
Findings could streamline enrollment for Alzheimer's clinical trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results